Awareness and Perception of Glaucoma Among Patients Attending Ophthalmology OPD in a Tertiary Care Hospital.

NCT ID: NCT07153588

Last Updated: 2025-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

379 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-28

Study Completion Date

2025-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Glaucoma is often called the "silent thief of vision" because it can slowly damage the optic nerve and cause permanent blindness if it is not found and treated early. Many people are not aware of glaucoma, its risk factors, or the importance of regular eye checkups.

This study is being conducted at the Ophthalmology Outpatient Department of Mardan Medical Complex, a large tertiary care hospital in Pakistan. The aim is to find out how much patients know and understand about glaucoma, and what beliefs or misconceptions they may have.

A total of 379 patients between the ages of 18 and 80 years will be asked to complete a simple questionnaire. The questions cover background information, eye history, knowledge about glaucoma, and attitudes toward screening and treatment. For patients who cannot read, trained staff will help them complete the questionnaire.

The information from this study will help doctors and health policy makers design better educational programs, improve public awareness, and encourage early eye screening. This can reduce the risk of irreversible vision loss caused by glaucoma

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Glaucoma is the leading cause of irreversible blindness worldwide and is often described as the "silent thief of vision." Because it progresses slowly and early symptoms are often missed, many patients only seek medical care after significant vision has already been lost. Lack of awareness and misconceptions about glaucoma are major barriers to early diagnosis and treatment, particularly in low- and middle-income countries.

This study is designed to measure the awareness and perception of glaucoma among patients attending the Ophthalmology Outpatient Department of a tertiary care hospital in Mardan, Pakistan. Using a structured questionnaire, researchers will collect information on four domains:

Sociodemographic details (age, gender, education, occupation, residence, and family history of glaucoma)

Ocular history (previous eye disease, surgery, or diagnosis of glaucoma)

Awareness of glaucoma (understanding of risk factors, symptoms, and treatment)

Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness to undergo screening or learn more).

A total of 379 participants will be included, and assistance will be provided for patients who cannot read or write to ensure accurate responses. Statistical analysis will be used to identify patterns and factors associated with higher or lower awareness levels.

The findings are expected to highlight critical knowledge gaps, common misconceptions, and areas where targeted educational efforts are most needed. By identifying who is most at risk of poor awareness, this study will provide evidence for developing effective public health interventions, awareness campaigns, and screening programs. Ultimately, the results aim to support earlier diagnosis and better management of glaucoma, reducing preventable vision loss in the community.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Level of awareness

This study uses a structured, interviewer-assisted questionnaire as the main intervention. The questionnaire is designed to assess patients' awareness and perception of glaucoma. It includes four sections:

Sociodemographic information (age, gender, education, occupation, residence, family history)

Ocular history (diagnosis of glaucoma, history of eye disease, surgery, or previous eye checkups)

Awareness of glaucoma (understanding of risk factors, symptoms, prevention, and treatment options)

Perceptions and attitudes (beliefs about curability, reversibility of vision loss, and willingness for screening and education).

For illiterate participants, trained research staff will administer the questionnaire verbally without influencing responses. The data collection method distinguishes this intervention from treatment-based studies, as it focuses on knowledge assessment and perception analysis rather than a medical or surgical procedure.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients between 18 and 80 years of age attending the Ophthalmology Outpatient Department (new or follow-up cases).
* Patients with ocular conditions, including diagnosed glaucoma and other eye pathologies.

Exclusion Criteria

* Patients with cognitive impairment or mental illness that limits their ability to understand or respond to the questionnaire.
* Patients with ocular malignancy or active ocular bleeding.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bacha Khan Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Malik Shayan Ali Khan

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mardan Medical Comlex, Mardan

Mardan, KPK, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ref no. 771/BKMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.